Literature DB >> 10816494

Investigation into the mechanism of gamma interferon-mediated inhibition of Toxoplasma gondii in murine astrocytes.

S K Halonen1, L M Weiss.   

Abstract

Toxoplasma gondii is an obligate intracellular parasite that is a common opportunistic pathogen of the central nervous system in AIDS patients. Gamma interferon (IFN-gamma) alone or in combination with interleukin-1 (IL-1), IL-6, or tumor necrosis factor alpha significantly inhibits the growth of T. gondii in murine astrocytes, suggesting these are important nonimmune effector cells in the brain. Inhibition was found to be independent of a nitric oxide-mediated or tryptophan starvation mechanism. Both reactive oxygen intermediates and iron deprivation are IFN-gamma-mediated mechanisms known to operate against intracellular parasites in other cell types. Astrocytes generated from mice genetically deficient in the production of reactive oxygen intermediates (phox(-/-) mice) were found to inhibit growth of T. gondii when stimulated with IFN-gamma alone or in combination with other cytokines. The reactive oxygen inhibitor catalase and the reactive oxygen scavengers mannitol and thiourea failed to reverse the IFN-gamma-induced inhibition of T. gondii in astrocytes. These data indicate that IFN-gamma-induced inhibition in astrocytes is independent of reactive oxygen intermediates. IFN-gamma-induced inhibition could not be reversed by the addition of iron salts, ferric citrate, ferric nitrate, or ferric transferrin. Pretreatment of astrocytes with desferrioxamine also did not induce the inhibition of T. gondii. These data indicate that the mechanism of IFN-gamma inhibition was not due to iron deprivation. IFN-gamma had no effect on T. gondii invasion of astrocytes, but inhibition of growth and loss of tachyzoite vacuoles were evident in IFN-gamma-treated astrocytes by 24 h after invasion. Overall, these data suggest that IFN-gamma-activated astrocytes inhibit T. gondii by an as-yet-unknown mechanism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10816494      PMCID: PMC97618          DOI: 10.1128/IAI.68.6.3426-3430.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Growth and development of Toxoplasma gondii in human neurons and astrocytes.

Authors:  S K Halonen; W D Lyman; F C Chiu
Journal:  J Neuropathol Exp Neurol       Date:  1996-11       Impact factor: 3.685

2.  Tissue cyst rupture in mice chronically infected with Toxoplasma gondii. An immunocytochemical and ultrastructural study.

Authors:  D J Ferguson; W M Hutchison; E Pettersen
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

3.  Phagosome acidification blocked by intracellular Toxoplasma gondii.

Authors:  L D Sibley; E Weidner; J L Krahenbuhl
Journal:  Nature       Date:  1985 May 30-Jun 5       Impact factor: 49.962

Review 4.  Mechanisms of innate resistance to Toxoplasma gondii infection.

Authors:  J Alexander; T M Scharton-Kersten; G Yap; C W Roberts; F Y Liew; A Sher
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-09-29       Impact factor: 6.237

Review 5.  Toxoplasmic encephalitis in AIDS.

Authors:  B J Luft; J S Remington
Journal:  Clin Infect Dis       Date:  1992-08       Impact factor: 9.079

6.  Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation.

Authors:  R T Gazzinelli; I Eltoum; T A Wynn; A Sher
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

7.  Pathophysiology of toxoplasmosis.

Authors:  J K Frenkel
Journal:  Parasitol Today       Date:  1988-10

8.  CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells.

Authors:  F T Hakim; R T Gazzinelli; E Denkers; S Hieny; G M Shearer; A Sher
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

9.  Gamma interferon induces rapid and coordinate activation of mitogen-activated protein kinase (extracellular signal-regulated kinase) and calcium-independent protein kinase C in human monocytes.

Authors:  M K Liu; R W Brownsey; N E Reiner
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

10.  Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.

Authors:  G S Yap; A Sher
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

View more
  17 in total

1.  Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase.

Authors:  W Däubener; B Spors; C Hucke; R Adam; M Stins; K S Kim; H Schroten
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

2.  Dendritic cells as effector cells: gamma interferon activation of murine dendritic cells triggers oxygen-dependent inhibition of Toxoplasma gondii replication.

Authors:  F Aline; D Bout; I Dimier-Poisson
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

3.  Microarray analysis of IFN-gamma response genes in astrocytes.

Authors:  Sandra K Halonen; Tyson Woods; Kate McInnerney; Louis M Weiss
Journal:  J Neuroimmunol       Date:  2006-04-21       Impact factor: 3.478

Review 4.  Toxoplasma gondii invasion and replication in astrocyte primary cultures and astrocytoma cell lines: systematic review of the literature.

Authors:  Carla O Contreras-Ochoa; Alfredo Lagunas-Martínez; Jaime Belkind-Gerson; Dolores Correa
Journal:  Parasitol Res       Date:  2012-06       Impact factor: 2.289

Review 5.  The molecular biology and immune control of chronic Toxoplasma gondii infection.

Authors:  Xiao-Yu Zhao; Sarah E Ewald
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

6.  In vitro investigation of host resistance to Toxoplasma gondii infection in microglia of BALB/c and CBA/Ca mice.

Authors:  Y R Freund; N T Zaveri; H S Javitz
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

7.  Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication.

Authors:  Daniel Degrandi; Elisabeth Kravets; Carolin Konermann; Cornelia Beuter-Gunia; Verena Klümpers; Sarah Lahme; Eva Rasch; Anne K Mausberg; Sandra Beer-Hammer; Klaus Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

8.  The gamma interferon (IFN-gamma)-inducible GTP-binding protein IGTP is necessary for toxoplasma vacuolar disruption and induces parasite egression in IFN-gamma-stimulated astrocytes.

Authors:  T Melzer; A Duffy; L M Weiss; S K Halonen
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

Review 9.  Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence.

Authors:  Ira J Blader; Jeroen P Saeij
Journal:  APMIS       Date:  2009-05       Impact factor: 3.205

10.  Disruption of the Toxoplasma gondii parasitophorous vacuole by IFNgamma-inducible immunity-related GTPases (IRG proteins) triggers necrotic cell death.

Authors:  Yang O Zhao; Aliaksandr Khaminets; Julia P Hunn; Jonathan C Howard
Journal:  PLoS Pathog       Date:  2009-02-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.